title: Status migrainosus in children and adolescents.
abstract: Data concerning status migrainosus in children and adolescents is sparse. The varied clinical presentations, diagnostic evaluation, and treatment modalities are discussed.
authors.affiliation: Department of Pediatric Neurology, The Cleveland Clinic Foundation, OH 44195, USA.
authors.forename: N D
authors.initials: ND
authors.lastname: Akhtar
authors.forename: M A
authors.initials: MA
authors.lastname: Murray
authors.forename: A D
authors.initials: AD
authors.lastname: Rothner
mesh_terms: D000293:Adolescent; D002648:Child; D003937:Diagnosis, Differential; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008297:Male; D008614:Meperidine / Q000008:administration & dosage / Q000009:adverse effects; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D008881:Migraine Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D018170:Sumatriptan / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D004087:Dihydroergotamine; D018170:Sumatriptan; D008614:Meperidine; D011239:Prednisolone; D008775:Methylprednisolone